Zhang M, Guo A, Wu J, Wang H, et al. Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China. Cephalalgia 2025;45:3331024251371686.
PMID: 41066271